DK406987A - Nye bisfosfonsyrederivater, deres fremstilling og brug - Google Patents
Nye bisfosfonsyrederivater, deres fremstilling og brugInfo
- Publication number
- DK406987A DK406987A DK406987A DK406987A DK406987A DK 406987 A DK406987 A DK 406987A DK 406987 A DK406987 A DK 406987A DK 406987 A DK406987 A DK 406987A DK 406987 A DK406987 A DK 406987A
- Authority
- DK
- Denmark
- Prior art keywords
- novel compounds
- preparations
- aryl
- processes
- dose units
- Prior art date
Links
- 238000002360 preparation method Methods 0.000 title abstract 3
- 239000002253 acid Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 5
- 125000001931 aliphatic group Chemical group 0.000 abstract 2
- 210000000988 bone and bone Anatomy 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 1
- 102000002260 Alkaline Phosphatase Human genes 0.000 abstract 1
- 108020004774 Alkaline Phosphatase Proteins 0.000 abstract 1
- 208000006386 Bone Resorption Diseases 0.000 abstract 1
- 125000002723 alicyclic group Chemical group 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 230000024279 bone resorption Effects 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 230000004936 stimulating effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6536—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and sulfur atoms with or without oxygen atoms, as the only ring hetero atoms
- C07F9/6544—Six-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6536—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and sulfur atoms with or without oxygen atoms, as the only ring hetero atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB8530603 | 1985-12-12 | ||
| GB858530603A GB8530603D0 (en) | 1985-12-12 | 1985-12-12 | Chemical compounds |
| DK8600132 | 1986-12-10 | ||
| PCT/DK1986/000132 WO1987003598A1 (en) | 1985-12-12 | 1986-12-10 | Novel bisphosphonic derivatives, a method for their production and a pharmaceutical composition |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| DK406987D0 DK406987D0 (da) | 1987-08-05 |
| DK406987A true DK406987A (da) | 1987-08-05 |
| DK169678B1 DK169678B1 (da) | 1995-01-09 |
Family
ID=10589647
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK406987A DK169678B1 (da) | 1985-12-12 | 1987-08-05 | Nye bisfosfonsyrederivater, farmaceutisk præparat indeholdende disse, samt deres fremstilling og brug |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US4870063A (da) |
| EP (1) | EP0248854B1 (da) |
| JP (1) | JPS63501956A (da) |
| CA (1) | CA1287350C (da) |
| DE (1) | DE3670639D1 (da) |
| DK (1) | DK169678B1 (da) |
| GB (1) | GB8530603D0 (da) |
| WO (1) | WO1987003598A1 (da) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL86951A (en) * | 1987-07-06 | 1996-07-23 | Procter & Gamble Pharma | Methylene phosphonoalkylphosphinates and pharmaceutical preparations containing them |
| US5227506A (en) * | 1989-09-06 | 1993-07-13 | Merck & Co., Inc. | Acyloxymethyl esters of bisphosphonic acids as bone resorption inhibitors |
| DE69023844T2 (de) * | 1989-09-06 | 1996-06-20 | Merck & Co Inc | Acyloxymethylester der Bisphonsäuren als Knochenresorptions-Inhibitoren. |
| FI89366C (fi) * | 1990-12-20 | 1993-09-27 | Leiras Oy | Foerfarande foer framstaellning av nya farmakologiskt anvaendbara metylenbisfosfonsyraderivat |
| US5350743A (en) * | 1991-02-07 | 1994-09-27 | Kaken Pharmaceutical Co., Ltd. | Bisphosphonic acid derivatives, as bone resorption inhibitors |
| JPH05163150A (ja) * | 1991-05-13 | 1993-06-29 | E R Squibb & Sons Inc | アテローム性動脈硬化症の抑制・治療剤 |
| FR2703590B1 (fr) * | 1993-04-05 | 1995-06-30 | Sanofi Elf | Utilisation de derives d'acide bisphosphonique pour la preparation de medicaments destines a favoriser la reparation osseuse . |
| US20010007863A1 (en) * | 1998-06-18 | 2001-07-12 | Merck & Co., Inc. | Wet granulation formulation for bisphosphonic acids |
| US5616571A (en) * | 1995-06-06 | 1997-04-01 | Merck & Co., Inc. | Bisphosphonates prevent bone loss associated with immunosuppressive therapy |
| US6376476B1 (en) * | 1996-12-13 | 2002-04-23 | Zymogenetics Corporation | Isoprenoid pathway inhibitors for stimulating bone growth |
| AU1525700A (en) | 1998-11-19 | 2000-06-05 | Board Of Trustees Of The University Of Arkansas, The | Increasing bone strength with selected bisphosphonates |
| US7041309B2 (en) * | 2002-06-13 | 2006-05-09 | Neuropro Technologies, Inc. | Spinal fusion using an HMG-CoA reductase inhibitor |
| WO2005090370A1 (en) | 2004-02-05 | 2005-09-29 | The Regents Of The University Of California | Pharmacologically active agents containing esterified phosphonates and methods for use thereof |
| EP2842559A3 (en) | 2005-04-08 | 2015-03-18 | Chimerix, Inc. | Compounds, compositions and methods for the treatment of viral infections and other medical disorders |
| EP1868628B1 (en) | 2005-04-08 | 2014-06-11 | Chimerix, Inc. | Compounds, compositions and methods for the treatment of poxvirus infections |
| EP2254582B1 (en) * | 2008-01-25 | 2016-01-20 | Chimerix, Inc. | Methods of treating viral infections |
| WO2011011519A1 (en) | 2009-07-21 | 2011-01-27 | Chimerix, Inc. | Compounds, compositions and methods for treating ocular conditions |
| EP2462152A4 (en) | 2009-08-03 | 2013-02-13 | Chimerix Inc | COMPOSITION AND METHODS FOR TREATING VIRAL INFECTIONS AND TUMORS OF VIRAL ORIGIN |
| US9006218B2 (en) | 2010-02-12 | 2015-04-14 | Chimerix Inc. | Nucleoside phosphonate salts |
| EP2563367A4 (en) | 2010-04-26 | 2013-12-04 | Chimerix Inc | METHODS OF TREATING RETROVIRAL INFECTIONS AND ASSOCIATED DOSAGE REGIMES |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PH9776A (en) * | 1967-12-11 | 1976-03-17 | M Francis | Compositions for inhibiting anomalous deposition and mobilization of calcium phosphate in animal tissue and method of use |
| JPS5095227A (da) * | 1973-12-26 | 1975-07-29 | ||
| US4264768A (en) * | 1978-08-09 | 1981-04-28 | Petrolite Corporation | Di-quaternary ammonium salts of α-1,4-thiazine alkanephosphonic acids |
| US4311663A (en) * | 1978-08-09 | 1982-01-19 | Petrolite Corporation | α-1,4-Thiazine alkanephosphonic acids as corrosion inhibitors |
| DE3225469A1 (de) * | 1982-07-05 | 1984-01-05 | Schering AG, 1000 Berlin und 4709 Bergkamen | Diphosphonsaeure-derivate und diese enthaltende pharmazeutische praeparate |
| DE3232998A1 (de) * | 1982-09-04 | 1984-03-08 | Henkel KGaA, 4000 Düsseldorf | Diphosphonsaeuren |
-
1985
- 1985-12-12 GB GB858530603A patent/GB8530603D0/en active Pending
-
1986
- 1986-12-10 US US07/090,980 patent/US4870063A/en not_active Expired - Fee Related
- 1986-12-10 WO PCT/DK1986/000132 patent/WO1987003598A1/en active IP Right Grant
- 1986-12-10 JP JP62500254A patent/JPS63501956A/ja active Pending
- 1986-12-10 EP EP87900075A patent/EP0248854B1/en not_active Expired - Lifetime
- 1986-12-10 DE DE8787900075T patent/DE3670639D1/de not_active Expired - Fee Related
- 1986-12-11 CA CA000525118A patent/CA1287350C/en not_active Expired - Fee Related
-
1987
- 1987-08-05 DK DK406987A patent/DK169678B1/da active
Also Published As
| Publication number | Publication date |
|---|---|
| JPS63501956A (ja) | 1988-08-04 |
| EP0248854B1 (en) | 1990-04-25 |
| DK169678B1 (da) | 1995-01-09 |
| CA1287350C (en) | 1991-08-06 |
| DE3670639D1 (de) | 1990-05-31 |
| US4870063A (en) | 1989-09-26 |
| DK406987D0 (da) | 1987-08-05 |
| WO1987003598A1 (en) | 1987-06-18 |
| GB8530603D0 (en) | 1986-01-22 |
| EP0248854A1 (en) | 1987-12-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK406987A (da) | Nye bisfosfonsyrederivater, deres fremstilling og brug | |
| HUT47217A (en) | Process for producing pharmaceutical compositions containing indol derivatives as active components | |
| RU97115713A (ru) | Соединения, содержащие бензопиран и способ их применения | |
| HUT40626A (en) | Process for producing new compounds of sceletal muscules relaxing activity and pharmaceutical compositions containing them as active agents | |
| FI842760A0 (fi) | Menetelmä terapeuttisesti aktiivisten imidatsoliumyhdisteiden valmistamiseksi | |
| ES8206511A1 (es) | Procedimiento para la preparacion de derivados de isoquino- leina | |
| ATE123944T1 (de) | Verwendung von trifluormethylphenyl- tetrahydropyridinen zur herstellung von arzneimitteln zur behandlung anxio-depressiver erkrankungen. | |
| DE2960194D1 (en) | Lactam-n-acetic acids, their amides, process for their preparation and therapeutic compositions containing them | |
| DE3061693D1 (en) | Secondary amines, their preparation and use in pharmaceutical compositions | |
| ATE161725T1 (de) | Verwendung von phosphatdiestern zur behandlung von erkrankungen der retina | |
| NO165195C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive nye derivater av 4,5-dihydro-oksazolyl-2-((2-pyridyl)-metyl-tio- eller metylsulfinyl)-benz- eller tienoimidazoler. | |
| IL81337A (en) | Heptanoyl-glu-asp-ala-amino acid immunostimulants,process for their preparation and pharmaceutical compositions containing them | |
| PT82848B (pt) | Processo para a preparacao de novas 5,11-dihidro-6h-pirido{2,3-b} {1,4}-benzodiazepina-6-onas substituidas na posicao 11 e de composicoes farmaceuticas que as contem | |
| ES557149A0 (es) | Un procedimiento para la preparacion de derivados peptidicos de histidinilprolinamida. | |
| HUT44781A (en) | Process for production of 2-benzimidasolile-alkyl-tioderivatives and medical preparatives containing them as active substance | |
| HUT48265A (en) | Process for producing phosphorous-containing 2-isoxazolines and isoxazoles and pharmaceutical compositions containing them or theyr salts as active components | |
| NO873571L (no) | Fremgangsmaate for fremstilling av et terapeutisk virksomtpreparat. | |
| AR005724A1 (es) | Derivados de ureido biologicamente activos utiles en el tratamiento de esclerosis multiple | |
| PH25352A (en) | Tetraoxo compounds, pharmaceutical compostions | |
| SU1655504A1 (ru) | Способ лечени эндометритов у коров | |
| NO158676C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-furyl-3,4-dihydroisokinolin-derivater. | |
| SU1653781A1 (ru) | Средство дл лечени эндометритов у коров | |
| RU1768172C (ru) | Способ лечени эндометритов у коров | |
| ES2066522T3 (es) | Nuevos derivados de acidos p-oxibenzoicos, procedimiento para su preparacion y su utilizacion como medicamentos. | |
| NO156410C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive 6aaa-methylprednisolonderivater. |